US equities
|
NVDA
$125.53
▼-14.01%
ANT
$88.91
▼-8.50%
MU
$594.51
▼-13.89%
AMD
$424.39
▼-13.25%
AAPL
$342.56
▼-1.90%
MSFT
$484.52
▼-2.77%
AMZN
$246.82
▼-4.10%
AVGO
$304.41
▼-12.19%
NVDA
$125.53
▼-14.01%
ANT
$88.91
▼-8.50%
MU
$594.51
▼-13.89%
AMD
$424.39
▼-13.25%
AAPL
$342.56
▼-1.90%
MSFT
$484.52
▼-2.77%
AMZN
$246.82
▼-4.10%
AVGO
$304.41
▼-12.19%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Latest News about Gregory D/ Gorgas
Recent news which mentions Gregory D/ Gorgas
Artelo Q2 Net Loss Declines 33% YoY, Here Is What You Need To Know
August 10, 2023
Tickers
ARTL
Tags
Gregory D/ Gorgas
ARTL
Benzinga
From
Benzinga
Artelo Unvails New Data On ART26.12 Demonstrating Positive Effects In Multiple Models Of Neuropathic Pain
June 27, 2023
Tickers
ARTL
Tags
Market News
Gregory D/ Gorgas
ARTL
From
Benzinga
Artelo Biosciences Presents Groundbreaking Research At Annual CBD Symposium In Canada
June 26, 2023
Tickers
ARTL
Tags
ARTL
Gregory D/ Gorgas
General
From
Benzinga
Artelo Biosciences Reveals Positive Pre-Clinical Results Of ART26.12, A Novel FABP5 Inhibitor, In Alleviating Chemotherapy-Induced Pain
June 27, 2022
Tickers
ARTL
Tags
Market News
Saoirse O’Sullivan
Benzinga
From
Benzinga